About Vivitide LAR 30 (Octreotide LAR Injection 30mg)
Vivitide LAR 30 (Octreotide LAR Injection 30mg) is a peerless solution for managing acromegaly, neuroendocrine tumors, carcinoid tumors, and VIPomas, formulated as a white to off-white powder for injectable suspension. Featuring the classic strength of Octreotide Acetate, each box contains a single-use vial and solvent ampoule. Scarce in availability and offered at an unbeatable price, this noteworthy medicine complies strictly with national drug authority guidelines. It must be administered intramuscularly by healthcare professionals and stored below 25C. Secure your purchase for reliable hormonal therapy from Samarth Life Sciences.
Targeted Application and Competitive Edge
Vivitide LAR 30's surface of application is strictly intramuscular, ensuring optimal usage for adult patients. This classic injectable suspension stands out due to its noteworthy efficacy in treating rare endocrine disorders. The competitive advantages include peerless formulation, strict regulatory approval, and reliable delivery of therapeutic benefits, making it a preferred choice for specialists. Its precise administration by healthcare professionals ensures both safety and consistency in therapeutic outcomes.
Swift Delivery and Reliable Supply Solutions
Our supply network ensures prompt delivery of Vivitide LAR 30 across India, keeping outlay minimal for our clients. With adequate stock levels, the supply ability meets the needs of hospitals and authorized distributors efficiently. Sample valuation can be discussed for bulk orders, ensuring transparency in procurement. Each outlay reflects our commitment to quality and timeliness, making this hormone analogue injection accessible for healthcare institutions nationwide.
FAQ's of Vivitide LAR 30 (Octreotide LAR Injection 30mg):
Q: How is Vivitide LAR 30 administered?
A: Vivitide LAR 30 is administered as an intramuscular injection. It must be prepared and injected by a qualified healthcare professional following the guidelines indicated in the package insert.
Q: What conditions is Vivitide LAR 30 recommended for?
A: Vivitide LAR 30 is recommended for the treatment of acromegaly, neuroendocrine tumors, carcinoid tumors, and vasoactive intestinal peptide tumors (VIPomas) in adult patients.
Q: What is the process for purchasing Vivitide LAR 30?
A: To purchase Vivitide LAR 30, a valid prescription is required. The product is available to hospitals, licensed pharmacies, suppliers, traders, and wholesalers in India. Direct procurement can be arranged via authorized distributors.
Q: When should Vivitide LAR 30 be stored and used?
A: Store Vivitide LAR 30 below 25C and protect it from light and moisture. Use before the manufacturer's expiry date, as indicated on the packaging.
Q: What are the main benefits of Vivitide LAR 30?
A: Vivitide LAR 30 offers noteworthy control over hormone-related tumors and acromegaly, providing peerless therapeutic efficacy with a classic somatostatin analogue mechanism.
Q: Where can one get further information or samples of Vivitide LAR 30?
A: For samples, pricing, or further information about Vivitide LAR 30, contact the registered distributor or supplier associated with Samarth Life Sciences in India.